Deracoxib is a non-steroidal anti-inflammatory drug (NSAID) that is used for the treatment of pain and inflammation in dogs. Deracoxib impurities are unwanted substances that may be present in the drug product. These impurities can affect the safety and efficacy of the drug and therefore, it is important to identify and control them during the manufacturing process. The most common impurities in Deracoxib include related compounds, residual solvents, and degradation products. Analy